About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Communicating Clearly About Medicines: Proceedings of a ... Released: May 16, 2017
    The Roundtable on Health Literacy of the National Academies of Sciences, Engineering, and Medicine convened a workshop on communicating clearly about medicines. The workshop focused on the clarity of written information given to patients and consumers as printed or digital materials. The workshop was organized around presentations and panel discussions that explored the design of health-literate written materials and examples that illustrated implementation of research into the development of these materials. The workshop rapporteurs in brief have prepared this proceedings as a factual summation of the session discussions.
  • Global Health and the Future Role of the United States ... Released: May 15, 2017
    The United States has long been a leader in global health. Yet resources are not unlimited, and the case for continued commitment must be made. With support from a broad array of federal agencies, foundations, and private partners, the National Academies of Sciences, Engineering, and Medicine convened an ad hoc committee to identify global health priorities in light of current and emerging global health threats and challenges.
  • Training the Future Child Health Care Workforce to Improve ... Released: May 12, 2017
    Childhood diagnoses of cognitive, affective, and behavioral disorders are increasing in both absolute numbers and as a proportion of the total childhood population in the United States, and they are imposing a large and growing burden on children, youth, and families. However, the adoption of evidence-based interventions that have proven effective in preventing and treating behavioral health disorders in children has been slow. A contributing factor for this slow adoption may be that current training in many fields involving the behavioral health of children is falling short of meeting needs.
  • Integrating Clinical Research into Epidemic Response: The ... Released: April 12, 2017
    The 2014 Ebola epidemic in western Africa was the longest and deadliest Ebola outbreak in history, resulting in 28,616 cases and 11,310 deaths. In the midst of the rapidly spreading, highly dangerous contagious disease—with no Ebola-specific vaccines or therapeutics available to help curb the epidemic—the international community implemented clinical trials on investigational agents, not yet studied in humans for safety or efficacy.
  • A National Strategy for the Elimination of Hepatitis B and C ... Released: March 28, 2017
    Each year, hepatitis B virus and hepatitis C virus cause nearly 1.5 million deaths worldwide—more than HIV, tuberculosis, and malaria. Such loss of life comes at a cost to society through the direct expense of treatment as well as through the loss of adults in their prime. In an effort to describe a strategy for eliminating viral hepatitis as a U.S. public health problem by 2030, the National Academies, with support from the Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services, the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America, and the National Viral Hepatitis Roundtable, convened an expert committee to outline a national strategy.
  • Implementing Evidence-Based Prevention by Communities to ... Released: March 20, 2017
    Communities also represent the front line in addressing many behavioral health conditions experienced by children, adolescents, young adults, and their families. Given the importance of communities in shaping the health and well being of young people, the National Academies of Sciences, Engineering, and Medicine held a workshop in June 2016, to examine the implementation of evidence- based prevention by communities. Participants examined questions related to scaling up, managing, and sustaining science in communities. This publication summarizes the presentations and discussions from the workshop.
  • Health Insurance and Insights from Health Literacy: Helping ... Released: March 13, 2017
    The Roundtable on Health Literacy of the National Academies of Sciences, Engineering, and Medicine convened a public workshop to examine health insurance through the lens of health literacy, focusing on literacy related barriers to information and coverage as well as on possible solutions.
  • Therapeutic Development in the Absence of Predictive Animal ... Released: March 10, 2017
    Despite the high prevalence and burden of nervous system disorders, development of new therapeutics lags behind other disease areas. Gaps in understanding the underlying pathophysiology, a dearth of biomarkers, and limitations in the capacity of animal models to predict drug efficacy for human brain disorders have contributed to a high rate of late stage failures in drug development and decreased investment in neuroscience research programs at pharmaceutical companies. On September 12-13, 2016, the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders hosted a public workshop to explore opportunities to accelerate drug development absent predictive animal models.
  • Countering Violent Extremism Through Public Health Practice ... Released: February 17, 2017
    Countering violent extremism (CVE) consists of various prevention and intervention approaches to increase the resilience of communities and individuals to radicalization toward violent extremism, to provide nonviolent avenues for expressing grievances, and to educate communities about the threat of recruitment and radicalization to violence.
  • Integration of FDA and NIOSH Processes Used to Evaluate ... Released: February 01, 2017
    The Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) have responsibilities for evaluating and regulating respiratory protective devices (RPDs) for health care workers. To provide input to NIOSH and FDA and to discuss potential next steps to integrate the two agencies’ processes to certify and approve N95 respirators for use in health care settings, a workshop was held by the National Academies of Sciences, Engineering, and Medicine (the National Academies).